Published in J Gen Virol on October 01, 2007
Hepatitis B: Epidemiology and prevention in developing countries. World J Hepatol (2012) 2.23
The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol Int (2008) 1.77
Detection of highly prevalent hepatitis B virus coinfection among HIV-seropositive persons in Ghana. J Clin Microbiol (2010) 1.20
Slave trade and hepatitis B virus genotypes and subgenotypes in Haiti and Africa. Emerg Infect Dis (2009) 1.16
Diagnostic algorithm for HBV safe transfusion. Blood Transfus (2009) 1.08
Prevalence, infectivity and correlates of hepatitis B virus infection among pregnant women in a rural district of the Far North Region of Cameroon. BMC Public Health (2015) 0.99
Characterization of genotype-specific carboxyl-terminal cleavage sites of hepatitis B virus e antigen precursor and identification of furin as the candidate enzyme. J Virol (2009) 0.96
Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan. J Clin Microbiol (2010) 0.89
Hepatitis B in Ghana: a systematic review & meta-analysis of prevalence studies (1995-2015). BMC Infect Dis (2016) 0.88
The clinical implications of hepatitis B virus genotypes and HBeAg in pediatrics. Rev Med Virol (2016) 0.86
High endemicity and low molecular diversity of hepatitis B virus infections in pregnant women in a rural district of North Cameroon. PLoS One (2013) 0.85
Epidemiology and molecular characterization of hepatitis B virus infection in isolated villages in the Western Brazilian Amazon. Am J Trop Med Hyg (2012) 0.83
Prevalence and virological profiles of hepatitis B infection in human immunodeficiency virus patients. World J Hepatol (2012) 0.83
Virologic characteristics of hepatitis B virus in patients infected via maternal-fetal transmission. World J Gastroenterol (2008) 0.83
Hepatitis B virus infection among HIV-infected pregnant women in Malawi and transmission to infants. J Hepatol (2013) 0.79
Hepatitis B virus infection does not significantly influence Plasmodium parasite density in asymptomatic infections in Ghanaian transfusion recipients. PLoS One (2012) 0.76
Low level of Hepatitis B knowledge and awareness among pregnant women in the Kintampo North Municipality: implications for effective disease control. Ghana Med J (2016) 0.75
Hepatitis B virus genotypes among chronic hepatitis B patients reporting at Korle-Bu teaching hospital, Accra, Ghana. Pan Afr Med J (2016) 0.75
Prevalence of blood borne viruses in IVF: an audit of a fertility Centre. JBRA Assist Reprod (2016) 0.75
Limited Genetic Diversity of Hepatitis B Virus in the General Population of the Offin River Valley in Ghana. PLoS One (2016) 0.75
Screening and diagnosis of HBV in low-income and middle-income countries. Nat Rev Gastroenterol Hepatol (2016) 0.75
Mother-to-child transmission of hepatitis B: extent of knowledge of physicians and midwives in Eastern region of Ghana. BMC Public Health (2016) 0.75
Seroprevalence and associated risk factors of hepatitis B virus among pregnant women in southern Ethiopia: a hospital-based cross-sectional study. Epidemiol Health (2016) 0.75
Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol (2008) 3.50
Predonation screening of blood donors with rapid tests: implementation and efficacy of a novel approach to blood safety in resource-poor settings. Transfusion (2005) 3.08
Humanitarian ventures or 'fistula tourism?': the ethical perils of pelvic surgery in the developing world. Int Urogynecol J Pelvic Floor Dysfunct (2006) 2.14
The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med (2009) 2.06
Transfusion-transmitted hepatitis B virus infection. J Hepatol (2009) 1.70
Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med (2011) 1.69
Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa. J Virol (2003) 1.50
Identification and characterization of persistent human erythrovirus infection in blood donor samples. J Virol (2004) 1.43
Persistence of HTLV-I in blood components after leukocyte depletion. Blood (2002) 1.39
Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood (2005) 1.39
Blood donor screening for parvovirus B19 in Germany and Austria. Transfusion (2007) 1.35
Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1. J Virol Methods (2004) 1.33
Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients. J Hepatol (2008) 1.30
Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol (2007) 1.28
Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J Hepatol (2008) 1.25
Dating the origin and dispersal of hepatitis B virus infection in humans and primates. Hepatology (2013) 1.19
Sensitivity of HCV RNA and HIV RNA blood screening assays. Transfusion (2002) 1.15
Transfusion in sub-Saharan Africa: does a Western model fit? J Clin Pathol (2007) 1.06
Characterization of HBV DNA+/HBsAg- blood donors in Poland identified by triplex NAT. Hepatology (2006) 1.04
Hepatitis C virus and hepatitis B virus bind to heparin: purification of largely IgG-free virions from infected plasma by heparin chromatography. J Gen Virol (2005) 1.03
Simultaneous visual detection of multiple viral amplicons by dipstick assay. J Clin Microbiol (2005) 1.02
Molecular characterization of occult hepatitis B virus in genotype E-infected subjects. J Gen Virol (2008) 1.01
Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain. Transfusion (2009) 1.00
Protective effect of HLA-B57 on HCV genotype 2 infection in a West African population. J Med Virol (2007) 1.00
Full genome characterization of hepatitis B virus strains from blood donors in Iran. J Med Virol (2011) 1.00
Characterization of periplasmic protein BP26 epitopes of Brucella melitensis reacting with murine monoclonal and sheep antibodies. PLoS One (2012) 1.00
Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence. Gut (2012) 0.99
A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol (2009) 0.98
External financial aid to blood transfusion services in sub-Saharan Africa: a need for reflection. PLoS Med (2012) 0.98
A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assays. Transfusion (2010) 0.97
Multiplex real-time PCR for the detection and quantification of latent and persistent viral genomes in cellular or plasma blood fractions. J Virol Methods (2008) 0.97
Evaluation of a new hepatitis B virus surface antigen rapid test with improved sensitivity. J Clin Microbiol (2008) 0.96
Transmissibility of hepatitis B virus (HBV) infection through blood transfusion from blood donors with occult HBV infection. Clin Infect Dis (2011) 0.95
A probable case of hepatitis B virus transfusion transmission revealed after a 13-month-long window period. Transfusion (2008) 0.94
Prevalence of persistent and latent viruses in untreated patients infected with HIV-1 from Ghana, West Africa. J Med Virol (2009) 0.93
Nucleic acid testing (NAT) in high prevalence-low resource settings. Biologicals (2010) 0.93
Duplex molecular assay intended for point-of-care diagnosis of influenza A/B virus infection. J Clin Microbiol (2013) 0.92
The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan. Transfusion (2009) 0.92
Hepatitis B virus (HBV) infection and recombination between HBV genotypes D and E in asymptomatic blood donors from Khartoum, Sudan. J Clin Microbiol (2010) 0.89
Investigating the prevalence of transfusion transmission of Plasmodium within a hyperendemic blood donation system. Transfusion (2012) 0.89
Antibody detection and kinetics of antibody production during early stages of immunization with hepatitis B virus vaccine. Clin Vaccine Immunol (2007) 0.89
Characterization of occult hepatitis B virus infection from blood donors in China. J Clin Microbiol (2011) 0.89
Differential reactivity of putative genotype 2 hepatitis C virus F protein between chronic and recovered infections. J Gen Virol (2008) 0.89
Nucleic acid dipstick test for molecular diagnosis of pandemic H1N1. J Clin Microbiol (2010) 0.87
Deletions and recombinations in the core region of hepatitis B virus genotype E strains from asymptomatic blood donors in Guinea, west Africa. J Gen Virol (2009) 0.87
Comparison of seven hepatitis B virus (HBV) nucleic acid testing assays in selected samples with discrepant HBV marker results from United States blood donors. Transfusion (2014) 0.86
Higher viral load may explain the dominance of CRF02_AG in the molecular epidemiology of HIV in Ghana. AIDS (2004) 0.86
Recombinant interferon-γ lentivirus co-infection inhibits adenovirus replication ex vivo. PLoS One (2012) 0.86
Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic. J Clin Microbiol (2006) 0.85
Effects of transfusion on human erythrovirus B19-susceptible or -infected pediatric recipients in a genotype 3-endemic area. Transfusion (2006) 0.85
Can family or replacement blood donors become regular volunteer donors? Transfusion (2013) 0.84
Infection of common marmosets with hepatitis C virus/GB virus-B chimeras. Hepatology (2014) 0.84
Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system. Transfusion (2003) 0.83
Infection frequency of hepatitis C virus and IL28B haplotypes in Papua New Guinea, Fiji, and Kiribati. PLoS One (2013) 0.83
Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors. Transfusion (2005) 0.82
Hepatitis B virus DNA splicing in Lebanese blood donors and genotype A to E strains: implications for hepatitis B virus DNA quantification and infectivity. J Clin Microbiol (2012) 0.82
Plasmodium genome in blood donors at risk for malaria after several years of residence in Italy. Transfusion (2014) 0.82
Malaria and transfusion: a neglected subject coming back to the forefront. Clin Infect Dis (2010) 0.81
Hepatitis C virus interacts with human platelet glycoprotein VI. J Gen Virol (2006) 0.81
GB virus C and HIV-1 RNA load in single virus and co-infected West African individuals. AIDS (2006) 0.80
Reverse vertical transmission of hepatitis B virus (HBV) infection from a transfusion-infected newborn to her mother. J Hepatol (2011) 0.80
Maternal-fetal transmission of human parvovirus B19 genotype 3. J Infect Dis (2006) 0.80
Chimeric monoclonal antibodies to hypervariable region 1 of hepatitis C virus. J Gen Virol (2005) 0.80
Seroprevalence of west nile virus in ghana. Viral Immunol (2009) 0.80
Characterization of hepatitis B virus in Turkish blood donors, and the prevalence of the SP1 splice variant. J Med Virol (2011) 0.80
Risk assessment and cost-effectiveness/utility analysis. Biologicals (2009) 0.80
Molecular virology in transfusion medicine laboratory. Blood Transfus (2012) 0.79
Occult hepatitis B virus infection and transfusion. J Hepatol (2005) 0.79
Significance of monoclonal antibodies against the conserved epitopes within non-structural protein 3 helicase of hepatitis C virus. PLoS One (2013) 0.79
Inactivation of Plasmodium falciparum in whole blood by riboflavin plus irradiation. Transfusion (2013) 0.79
Potential risk of blood transfusion-transmitted brucellosis in an endemic area of China. Transfusion (2014) 0.78
Human herpesvirus 8 transfusion transmission in Ghana, an endemic region of West Africa. Transfusion (2012) 0.78
West Nile virus and blood donors. Lancet (2003) 0.78
This article has been retracted: Trends in the frequency of blood donors donating blood to be tested for HIV in Shiraz from 2004 to 2006. Transfus Med (2010) 0.78
Fourteen-year experience of a tertiary hospital transfusion committee in West Africa. Transfusion (2014) 0.78
HIV safety in sub-Saharan Africa. Vox Sang (2010) 0.77
Specific amino acid substitutions in the S protein prevent its excretion in vitro and may contribute to occult hepatitis B virus infection. J Virol (2013) 0.77
Assessment of removal of human cytomegalovirus from blood components by leukocyte depletion filters using real-time quantitative PCR. Blood (2003) 0.77
Evidence of serological cross-reactivity between genotype 1 and genotype 3 erythrovirus infections. J Virol (2005) 0.77
Vertical transmission of HIV in Ghanaian women diagnosed in cord blood and post-natal samples. J Med Virol (2005) 0.77
Impact of host responses on control of hepatitis C virus infection in Chinese blood donors. Biochem Biophys Res Commun (2011) 0.77
Treatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood Storage. Shock (2015) 0.76
Hepatitis B virus infection does not significantly influence Plasmodium parasite density in asymptomatic infections in Ghanaian transfusion recipients. PLoS One (2012) 0.76
Hepatitis C virus antibody confirmation in resource-poor settings. Transfusion (2008) 0.75
Predonation testing of potential blood donors in resource-restricted settings. Transfusion (2005) 0.75
Estimation of HBV transfusion risk. Transfusion (2009) 0.75
International Association for Biologicals Symposium: "Advances in Transfusion Safety", Cambridge, UK. Foreword. Biologicals (2009) 0.75
AM Last Page. Medical education in Ghana. Acad Med (2012) 0.75
GB virus C genotype 1 is rarely transmitted vertically but acquired during infancy in West Africa. AIDS (2006) 0.75
Occult Hepatitis B Virus Infection in Hyperlipidemia Patients. Tohoku J Exp Med (2017) 0.75